Stock Comparison
DXCM vs MDT
DexCom Inc and Medtronic PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$33.38B
$110.76B
P/E (TTM)
35.0
23.7
Forward P/E
34.9
14.8
Price/Sales
6.7
3.1
Price/Book
12.7
2.3
EV/EBITDA
21.2
13.4
Dividend Yield
—
2.35%
Profitability
Net Margin
19.31%
13.20%
Operating Margin
21.45%
18.63%
Return on Equity
38.50%
9.84%
Return on Assets
10.30%
4.92%
Growth (YoY)
Revenue Growth
13.10%
9.90%
Earnings Growth
43.60%
18.30%
Price & Risk
Beta
1.4
0.6
52-Week High
$91.48
$103.74
52-Week Low
$54.84
$73.75
Analyst Target
$93.44
$98.44
Compare DXCM and MDT your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.